TBPH Operating Expenses
Theravance Biopharma Inc · Operating Expenses
TBPH Operating Expenses
Latest reported$88.59Mperiod ending
TBPH TTM Operating Expenses ($156.51M → $88.59M)
TTM operating expenses
High-resolution chart · PNG
TBPH operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 88,594,000 | |
| 87,132,000 | |
| 81,953,000 | |
| 73,634,000 | |
| 73,738,000 | |
| 75,315,000 | |
| 73,687,000 | |
| 70,678,000 | |
| 75,355,000 | |
| 75,795,000 | |
| 79,810,000 | |
| 81,050,000 | |
| 74,722,000 | |
| 73,502,000 | |
| 79,911,000 | |
| 103,066,000 | |
| 109,350,000 | |
| 116,054,000 | |
| 119,438,000 | |
| 109,606,000 | |
| 181,408,000 | |
| 242,661,000 | |
| 304,449,000 | |
| 374,465,000 | |
| 357,221,000 | |
| 338,663,000 | |
| 325,329,000 | |
| 302,984,000 | |
| 299,939,000 | |
| 304,941,000 | |
| 298,406,000 | |
| 301,255,000 | |
| 286,959,000 | |
| 280,597,000 | |
| 269,479,000 | |
| 251,283,000 | |
| 243,233,000 | |
| 228,297,000 | |
| 226,220,000 | |
| 220,307,000 | |
| 221,282,000 | |
| 220,874,000 | |
| 219,367,000 | |
| 226,865,000 | |
| 229,682,000 | |
| 237,161,000 | |
| 240,169,000 | |
| 220,460,000 | |
| 205,533,000 | |
| 185,089,000 | |
| 156,510,000 | |
| 179,400,000 | |
| 170,893,000 |